The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients

Ying Ding, Xiaojuan Yu, Lihua Wu, Ying Tan, Zhen Qu, Feng YuFrontiers in Immunology 2021 · DOI

TL;DR

This study reveals that C4d deposition is nearly ubiquitous in lupus nephritis (LN) kidney biopsies, with specific locations offering distinct clinical insights. Tubular basement membrane (TBM) C4d correlates with disease activity, while arteriolar C4d is a significant predictor of renal microvascular lesions and poorer long-term renal outcomes, highlighting its prognostic value.

What Problem Does This Paper Address?

Lupus nephritis (LN) is a serious complication of systemic lupus erythematosus (SLE) that can lead to kidney failure. While complement activation is known to play a crucial role in LN pathogenesis, the specific role and significance of complement factor C4d deposition in different renal compartments within LN patients have remained unclear. Previous studies have yielded conflicting results regarding C4d's association with disease activity and its prognostic value. This paper aims to clarify the prevalence, localization, and clinical significance of C4d deposition in a well-defined cohort of LN patients, specifically investigating its relationship with clinico-pathological features and renal outcomes.

Methods

The researchers conducted a retrospective analysis of 325 patients with biopsy-proven LN. They collected detailed clinico-pathological data and performed immunohistochemical staining for C4d on renal biopsy specimens. C4d deposition was assessed in four key renal compartments: glomeruli, tubular basement membrane (TBM), arterioles, and peritubular capillaries (PTCs). The intensity and distribution of C4d staining were semi-quantitatively graded. Statistical analyses, including Spearman's rank-order correlation, Kruskal-Wallis tests, Mann-Whitney U-tests, Kaplan-Meier curves, and Cox regression models, were employed to explore the associations between C4d deposition patterns and various clinical, laboratory, and histopathological features, as well as renal outcomes.

Datasets

The study utilized a dataset of 325 patients with biopsy-proven lupus nephritis diagnosed between January 2000 and June 2008 at Peking University First Hospital. This dataset included comprehensive clinico-pathological data and renal biopsy samples. No new datasets were introduced.

Key Insights and Ideas

  • Ubiquitous C4d, Diverse Significance: C4d deposition is extremely common in LN kidneys (98.8%), but its meaning varies significantly depending on its location. This challenges a one-size-fits-all interpretation of C4d in kidney disease.
  • TBM C4d as a Disease Activity Marker: C4d deposition in the tubular basement membrane (TBM) is strongly linked to higher disease activity (SLEDAI) and more severe histopathological findings, suggesting it reflects active inflammation within the kidney.
  • Arteriolar C4d as a Prognostic Indicator: Arteriolar C4d deposition is a key finding, not just associated with renal microvascular lesions (RVLs) but also a significant predictor of worse long-term renal outcomes. This makes it a valuable marker for identifying patients at higher risk of kidney failure.
  • Complement Co-deposition Matters: The combined presence of arteriolar C4d and C3c deposition emerges as a particularly potent independent risk factor for poor renal outcomes, underscoring the complex interplay of complement pathways in LN progression.
  • RVLs and Complement Link: The strong association between arteriolar C4d and RVLs, including TMA lesions, suggests a shared complement-driven pathway contributing to microvascular damage in LN.

Key Results

  • Prevalence: C4d deposition was found in 321 out of 325 (98.8%) LN samples.
  • Localization: Deposits were most commonly found in glomeruli (98.2%), followed by TBM (43.7%), PTCs (33.8%), and arterioles (31.4%).
  • TBM C4d Associations: Patients with TBM C4d staining showed higher disease activity (SLEDAI), higher National Institutes of Health pathological activity and chronicity indices, and more frequent hematuria, leukocyturia, and acute kidney injury.
  • Arteriolar C4d Associations: Patients with arteriolar C4d deposition were significantly more likely to develop RVLs (91.2% vs. 78.0%, P=0.004), especially multiple types of RVLs.
  • Prognostic Value: Arteriolar C4d deposition was associated with worse renal outcomes (HR: 2.074, P=0.034). Co-deposition of arteriolar C4d and C3c was an independent risk factor for predicting renal outcomes (HR: 3.681, P=0.004).

Limitations and Future Work

The authors acknowledge that the diverse conclusions from different studies regarding C4d deposition might be attributed to variations in sample size, testing methods, and disease activity. They also note that while their study found a close association between arteriolar C4d deposition and RVLs, including TMA changes, the exact causal relationship and the role of complement activation in RVL pathogenesis require further investigation. The study suggests that arteriolar C4d deposition, especially in conjunction with C3c, might serve as an alternative test to identify patients who could benefit from anti-complement therapy. Future research should focus on larger cohorts and more detailed analyses to fully elucidate the role of C4d in the pathomechanisms of LN and its potential as a therapeutic target.

Summary updated

Abstract

C4d deposition was common in renal tissues from LN patients. TBM C4d deposition was related to the disease activity, and arteriolar C4d deposition was associated with RVLs and worse renal outcomes.
BibTeX
@inproceedings{ding2021spectrum,
  author = {Ying Ding and Xiaojuan Yu and Lihua Wu and Ying Tan and Zhen Qu and Feng Yu},
  title = {{The Spectrum of C4d Deposition in Renal Biopsies of Lupus Nephritis Patients}},
  booktitle = {Frontiers in Immunology},
  year = {2021},
  doi = {10.3389/fimmu.2021.654652},
}
Figure